Home›People›Charles Harwood
CH

Charles Harwood

Director at ACP Ulysses.

DirectorPublic company
Updated Oct 27, 2026·Latest SEC filing Feb 9, 2026·Suggest an edit

About Charles Harwood

Charles Harwood is a director at ACP Ulysses.

Charles Harwood reports to the SEC as a director of 3 public companies: OmniAb (OABI), Organogenesis Holdings (ORGO) and Syneos Health (SYNH).

Charles Harwood first appears on SEC filings in 2014.

Experience

This experience comes from SEC filings. The years are when the filings name Charles Harwood in the role, so the role may have started earlier or lasted longer.

ACP Ulysses Holdings, Inc.
Director
2018 – 2026 · New York, NY
OmniAb, Inc.
Director
2022 · Public company (OABI)
Organogenesis Holdings Inc.
Director
2016 – 2018 · Public company (ORGO)
Syneos Health, Inc.
Director
2014 – 2016 · Public company (SYNH)

Key Colleagues at Startups

The people Charles Harwood works with at each company, as listed on that company's latest Form D.

ACP Ulysses Holdings, Inc. · Form D/A, Feb 9, 2026
NF
BH
Brett Huselton
Executive officer
RG
MH
Michael Haratz
Executive officer
BB
Bekki Brown
Executive officer and director
EZ
Eddie Zhao
Director
KT
Karen Turner
Chief Financial Officer

Sources

  1. SECACP Ulysses Holdings, Inc. Form D/A, filed Feb 9, 2026
  2. SECForms 3, 4 and 5 filed by Charles Harwood (SEC filer 1624072)